Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain
This study is ongoing, but not recruiting participants.
Study NCT01290367   Information provided by Mesoblast, Ltd.

First Received on February 3, 2011.   Last Updated on April 19, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Degenerative Disc Disease
Additional conditions recognized in this trial
Back Pain
Intervertebral Disk Degeneration
Low Back Pain
More general conditions related to this trial
Bone Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neurologic Manifestations
Pain
Signs and Symptoms
Spinal Diseases
Interventions listed in this trial
Single Dose MPCs Injection
Single injection of saline solution
Single injection of hyaluronic acid
Additional drug interventions recognized in this trial
Hyaluronic Acid
More general drug interventions related to this trial
Adjuvants, Immunologic
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Mesoblast, Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services